Drug delivery news - the latest biotech news from Labiotech.eu

Home Drug delivery

Latest Posts

AAV research

News and Trends 12 May 2025

Pharma giants pull back on AAV research: what’s next for the gene therapy space?

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what’s on the horizon for drug delivery methods.

May 12, 2025 - 8 minutesmins - By Roohi Mariam Peter

gene therapy cystic fibrosis

In Depth 9 Apr 2025

Cystic fibrosis: is the next blockbuster a gene therapy?

Learn about the biotechs progressing their gene therapies for cystic fibrosis and why it might just be the breakthrough that patients need.

April 9, 2025 - 10 minutesmins - By Roohi Mariam Peter

Needle-free vaccines

In Depth 5 Feb 2025

Needle-free vaccines: Micron Biomedical, Vaxxas, and IntegriMedical bring their new technologies to patients

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in this space.

February 5, 2025 - 11 minutesmins - By Willow Shah-Neville

Cancer vaccines

In Depth 2 Dec 2024

The rise of cancer vaccines: A new era in immunotherapy

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors.

December 2, 2024 - 8 minutesmins - By Jules Adam

Unlocking AAV gene therapy potential: The role of successful characterization

Sponsored by 5 Nov 2024

Unlocking AAV gene therapy potential: The role of successful characterization

Explore the role and challenges of AAV characterization, the significance of capsid filling, and the best methods to enhance gene therapy.

November 5, 2024 - 8 minutesmins - By Ute Boronowsky

Nanotechnology companies

Best in Biotech 22 Oct 2024

Eight nanotechnology companies to watch out for

Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.

October 22, 2024 - 10 minutesmins - By Roohi Mariam Peter

ADVERTISEMENT

Sublingual delivery of GLP-1 receptor agonists

Sponsored by 1 Oct 2024

Sublingual delivery: the future for GLP-1 receptor agonists

Discover how GLP-1 receptor agonists, now thriving in obesity treatment, could benefit from a more patient-friendly sublingual delivery method.

October 1, 2024 - 7 minutesmins - By External Contributor

Pfizer GLP-1

In Depth 25 Sep 2024

How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market

Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ’90s.

September 25, 2024 - 9 minutesmins - By Jennifer Tsang

Vironexis

News and Trends 16 Sep 2024

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

Delve into Vironexis’ launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.

September 16, 2024 - 6 minutesmins - By Jules Adam

Poland biotech company

Best in Biotech 23 Apr 2024

Eight biotechnology companies leading the charge in Poland

Discover eight biotech companies at the forefront of Poland’s emerging biotech sector, which is becoming a hotspot for startups.

April 23, 2024 - 7 minutesmins - By Jules Adam

bladder cancer treatment

In Depth 17 Jan 2024

Bladder cancer treatment: where are we standing?

Bladder cancer is the 10th most common cancer. Delve into the most promising strides in bladder cancer treatment.

January 17, 2024 - 8 minutesmins - By Jules Adam

mRNA

News and Trends 11 Jul 2023

Inhaled mRNA medicines redefine respiratory disease treatment

By Carsten Rudolph, co-founder and CEO of Ethris Advancements in mRNA technology have led to the development of inhaled mRNA medicines, which hold tremendous potential for revolutionizing the treatment of respiratory diseases, an area with high unmet needs. However, the primary hurdle in its clinical application lies in the identification of a delivery system that […]

July 11, 2023 - 3 minutesmins - By External Contributor

ADVERTISEMENT